Variant report

Variant	nsv969774
Chromosome Location	chr9:10011936-10016071
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 132 )
Associated
traits (count: 112 )

Variant overlapped rSNPs/rCNVs (count:132 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527619754	chr9:10011939-10011940	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs144269761	chr9:10011948-10011949	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs570800726	chr9:10011963-10011964	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs533362291	chr9:10011972-10011973	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs74526073	chr9:10011984-10011985	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs560330615	chr9:10011994-10011995	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs113491760	chr9:10012040-10012041	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs535636177	chr9:10012057-10012058	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs192613223	chr9:10012076-10012077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs142249268	chr9:10012086-10012087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs376566552	chr9:10012090-10012091	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs10755990	chr9:10012093-10012094	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs111365006	chr9:10012149-10012150	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs139749107	chr9:10012158-10012159	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs562637262	chr9:10012247-10012248	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs576241286	chr9:10012256-10012257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs542025872	chr9:10012266-10012267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs531198905	chr9:10012279-10012280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs561914250	chr9:10012280-10012281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs572298060	chr9:10012285-10012286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs553861104	chr9:10012299-10012300	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs10809006	chr9:10012304-10012305	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs71497167	chr9:10012305-10012306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs146640872	chr9:10012349-10012350	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs548818390	chr9:10012361-10012362	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs549796488	chr9:10012363-10012364	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs563418011	chr9:10012404-10012405	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs10755991	chr9:10012424-10012425	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs532337888	chr9:10012425-10012426	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs183667710	chr9:10012447-10012448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs566100211	chr9:10012456-10012457	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs372919239	chr9:10012466-10012467	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs547579306	chr9:10012495-10012496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs188387239	chr9:10012518-10012519	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs181201115	chr9:10012525-10012526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs571925302	chr9:10012543-10012544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs539049130	chr9:10012595-10012596	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs556224945	chr9:10012620-10012621	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs10809007	chr9:10012626-10012627	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs535587322	chr9:10012627-10012628	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs141025729	chr9:10012631-10012632	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs7860568	chr9:10012637-10012638	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs150247531	chr9:10012646-10012647	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs376055044	chr9:10012660-10012661	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs564207746	chr9:10012661-10012662	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs185845279	chr9:10012671-10012672	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs543407633	chr9:10012713-10012714	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs563381739	chr9:10012724-10012725	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs558764214	chr9:10012738-10012739	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs529258186	chr9:10012755-10012756	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:112)

Disease	PMID	Source
abnormal development	18461090	CNVD
Disorders of sex development	21048976	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	20164920	CNVD
Lung cancer	20668451	CNVD
Schizophrenia	20838587	CNVD
Glioblastoma	18772890	CNVD
Glioblastoma multiforme	21390271	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	21764851	CNVD
Glioblastoma multiforme	22286061	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Gastric cancer	16891809	CNVD
Mental retardation	17847001	CNVD
Cutaneous squamous cell carcinomas	17420988	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung adenocarcinoma	17982442	CNVD
Breast cancer	21611746	CNVD

Chromatin state (count:17 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:10007200-10012400	Enhancers	iPS-20b Cell Line	embryonic stem cell
2	chr9:10008200-10012800	Enhancers	HUES64 Cell Line	embryonic stem cell
3	chr9:10008600-10013000	Enhancers	iPS-18 Cell Line	embryonic stem cell
4	chr9:10008600-10013400	Enhancers	HUES48 Cell Line	embryonic stem cell
5	chr9:10009400-10012600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr9:10009400-10012800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr9:10011800-10012400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr9:10011800-10012600	Weak transcription	HUES6 Cell Line	embryonic stem cell
9	chr9:10012400-10013000	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr9:10012400-10013800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr9:10012600-10012800	Enhancers	HUES6 Cell Line	embryonic stem cell
12	chr9:10012600-10013400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr9:10013000-10014000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
14	chr9:10013400-10014200	Weak transcription	HUES48 Cell Line	embryonic stem cell
15	chr9:10013800-10014000	Enhancers	iPS-20b Cell Line	embryonic stem cell
16	chr9:10014000-10014200	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr9:10014200-10014600	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links